Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$618K Buy
+26,200
New +$3.21M 0.04% 234
2024
Q4
Sell
-22,500
Closed -$139K 788
2024
Q3
$139K Sell
22,500
-518,800
-96% -$38.3M 0.02% 359
2024
Q2
$10.6M Buy
+541,300
New +$21M 1.26% 13
2022
Q4
Sell
-10,600
Closed -$9K 1695
2022
Q3
$9K Buy
+10,600
New +$254K ﹤0.01% 1351
2020
Q2
Sell
-11,100
Closed -$4K 1802
2020
Q1
$4K Buy
+11,100
New +$263K ﹤0.01% 1102

Other funds holding INSM

HAP Trading's INSM Position: Q1 2025 in Review

HAP Trading sold out of Insmed (INSM) in Q1 2025, closing a stake of 87,533 shares — an estimated $6.04M sold.

HAP Trading first reported a position in INSM in Q1 2024 and held it in 3 quarters. The position peaked at $6.09M in Q3 2024. 441 funds tracked by Wall St. Rank hold INSM as of Q1 2025.

  • HAP Trading reported no remaining Insmed position as of Q1 2025 after selling out during the quarter.
  • HAP Trading sold 87,533 Insmed shares in Q1 2025, an estimated $6.04M.
  • HAP Trading first reported a position in Insmed in Q1 2024 and held it in 3 quarters.
  • HAP Trading's Insmed position peaked at $6.09M in Q3 2024.
  • 441 funds tracked by Wall St. Rank held Insmed as of Q1 2025.

Based on HAP Trading's 13F filing for Q1 2025, filed 14 May 2025.